Recombinate
PATIENT INFORMATION
The patient and physician should discuss the risks and benefits of this product.
Although allergic type hypersensitivity reactions were not observed in any patient receiving RECOMBINATE rAHF on study, such reactions are theoretically possible. Patients should be informed of the early signs of hypersensitivity reactions including hives, generalized urticaria, tightness of the chest, wheezing, hypotension, and anaphylaxis. Patients should be advised to discontinue use of the product and contact their physician if these symptoms occur.
Generic Name: Antihemophilic Factor (Recombinant)
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Health Extras
Herbal First Aid
Herbal medicine is ancient, but only in recent years have many people started to take notice of its all natural healing powers. See more WebMD Videos »
Recombinate
Health Resources
Slideshows
Updated & New
RxList does not provide medical advice, diagnosis or treatment.